Buy Rating for Mediwound Driven by EscharEx’s Market Potential and Disruptive Role in Chronic Wound Care
Michael Okunewitch, an analyst from Maxim Group, maintained the Buy rating on Mediwound (MDWD – Research Report). The associated price target ...
Buy Rating for Mediwound Driven by EscharEx’s Promising Market Potential and Revenue Growth
Analyst Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on Mediwound (MDWD – Research Report) and keeping the price target ...
Compression Therapy Market Technologies and Applications Analysis 2025, with Profiles of Major Companies Operating in this Space
Global Compression Therapy Market Projected to Reach $5.6 Billion by 2030, Driven by Innovations and Aging Population ...
Future Market Insights11d
Global Venous Stents Industry Poised for Rapid Growth, Expected to Reach USD 2.2 Billion by 2033
Venous Stents Industry. According to the latest industry analysis from Future Market Insights, the global venous stents ...
Pharmaceutical Technology12d
Amesanar by RHEACELL for Diabetic Foot Ulcers: Likelihood of Approval
Amesanar is under clinical development by RHEACELL and currently in Phase II for Diabetic Foot Ulcers. According to GlobalData, Phase II drugs for Diabetic Foot Ulcers does not have sufficient ...
Pharmaceutical Technology12d
Sulodexide by Alfasigma for Venous Thromboembolism: Likelihood of Approval
Sulodexide is under clinical development by Alfasigma and currently in Phase III for Venous Thromboembolism. According to GlobalData, Phase III drugs for Venous Thromboembolism have a 60% phase ...
Is That Wound Not Healing? You Might Be Suffering From Gangrene
Non-healing wounds may signal gangrene, a severe condition caused by tissue death due to poor oxygen and blood flow. Early ...
Firstpost24d
Is flesh-eating bacteria that disfigure the body likely to spread in Australia?
A flesh-eating bacteria known as Buruli ulcer has become a growing concern in Australia. This comes as the coastal town of Batemans Bay in New South Wales reported two cases, whereas the southern ...
Nasdaq24d
MediWound To Provide Key Update On EscharEx Phase III Trial For Venous Leg Ulcers Next Month
The event will focus on EscharEx, an innovative biologic drug in late-stage development for chronic wound debridement, specifically targeting Venous Leg Ulcers (VLUs). The event will feature three ...
The New England Journal of Medicine25d
Nonsurgical Management of Chronic Venous Insufficiency
Chronic venous insufficiency manifests as a spectrum of signs and symptoms, including varicose veins, leg swelling, skin changes, and leg ulcers. The condition is caused primarily by venous ...
thenewdaily25d
Flesh-eating ulcer becomes ‘endemic’ in another state
The surprise discovery of flesh-eating ulcers hundreds of kilometres from existing case clusters has sparked concerns it has become entrenched in another state. Buruli ulcer has been known to ...
Sydney Morning Herald25d
Flesh-eating ulcer ‘endemic’ in coastal town with ‘significant risk’ of spread to Sydney
Add articles to your saved list and come back to them any time. A flesh-eating ulcer has taken root in a NSW holiday hotspot and poses a significant risk of spreading to Sydney. Batemans Bay on ...